Concomitant Use of β-Blockers & Sulfonylureas Ups Risk for Severe Hypoglycemia
This course discusses how the concomitant use of β-blockers and sulfonylureas increases the risk for severe hypoglycemia and how to gain aware of other medications that, when given together with sulfonylureas, increase the risk for hypoglycemia.
Click CE Information to start the course. Post Test and Evaluation must be completed to earn certificate of completion.